BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 3209914)

  • 1. A preliminary study of a combination chemotherapy with ifosfamide, adriamycin and cisplatin for endometrial carcinoma.
    Nishida T; Nagasue N; Kishi N; Imaishi K; Tateno N; Matsumura T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1883-8. PubMed ID: 3209914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
    Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of gynecological adenocarcinomas with a combination of ifosfamide, adriamycin and cisplatin.
    Nishida T; Nagasue N
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 May; 40(5):635-9. PubMed ID: 3133435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
    Zanetta G; Fei F; Mangioni C
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination chemotherapy using cyclophosphamide, adriamycin, and cisplatin in recurrent or advanced endometrial cancer--a preliminary report].
    Baba S; Kashimura M; Shinohara M; Kusano S; Sasayama T; Hamasaki K
    Gan No Rinsho; 1989 Feb; 35(3):371-7. PubMed ID: 2926985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ifosfamide, cisplatin, adriamycin combination chemotherapy in gynecologic cancer].
    Sawada M; Inagaki M; Hirota Y; Hongo J; Ozaki M
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3091-4. PubMed ID: 3674894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin and etoposide alternating ifosfamide, vincristine, epirubicin in small cell lung cancer.
    Unsal M; Erturk D
    Saudi Med J; 2003 Jun; 24(6):628-31. PubMed ID: 12847592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ifosfamide combination chemotherapy for advanced gynecologic malignancies].
    Li X; Liu L; Wu L
    Zhonghua Zhong Liu Za Zhi; 2000 Jul; 22(4):330-2. PubMed ID: 11778564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced endometrial carcinoma.
    Turbow MM; Ballon SC; Sikic BI; Koretz MM
    Cancer Treat Rep; 1985 May; 69(5):465-7. PubMed ID: 4039978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
    Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
    Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
    Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
    Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with "high-risk" endometrial cancer.
    Duska LR; Berkowitz R; Matulonis U; Muto M; Goodman A; McIntyre JF; Klein A; Atkinson T; Seiden MV; Campos S
    Gynecol Oncol; 2005 Jan; 96(1):198-203. PubMed ID: 15589601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential chemoradiation therapy with vinorelbine, ifosfamide, and cisplatin in stage IIIB non-small cell lung cancer: a phase II study.
    Baldini E; Silvano G; Tibaldi C; Campoccia S; Cionini L; Conte P
    Semin Oncol; 2000 Feb; 27(1 Suppl 1):28-32. PubMed ID: 10697041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
    Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of advanced endometrial carcinoma with doxorubicin and cisplatin: effects on both untreated and previously treated patients.
    Pasmantier MW; Coleman M; Silver RT; Mamaril AP; Quiguyan CC; Galindo A
    Cancer Treat Rep; 1985 May; 69(5):539-42. PubMed ID: 4039980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination therapy with carboplatin/cisplatin/ifosfamide/etoposide in ovarian cancer.
    Lund B; Hansen OP; Hansen HH; Hansen M
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):26-9. PubMed ID: 1411618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.